Expert panel recommends approving Covaxin for kids
The central drug regulator’s expert panel has recommended granting marketing authorisation with certain conditions to Bharat Biotech's Covaxin for restricted emergency use in children and adolescents in the age group of 2 to 18 years old.
View the full story here: https://timesofindia.indiatimes.com/india/expert-panel-recommends-approving-covaxin-for-kids/articleshow/86978499.cms